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The World Health Organization
(WHO) has set forth ambitious efforts to
control, and where possible, eliminate the
neglected tropical diseases (NTDs) that
contribute to poverty and ‘‘impair the
ability of those infected to achieve their full
potential, both developmentally and socio-
economically’’ [1,2]. This neglected dis-
ease initiative’s (NDI) purpose has been to
close the existing poverty gap between
individuals living in low/middle-income
and high-income countries, and thus
facilitate the achievement of the 2000
Millennium Developmental Goals [3].
The gap is still large. Yet, some marked
achievements of the NDI, including coor-
dinated administration of preventive che-
motherapy to nearly 670 million children
globally and the imminent elimination of
dracunculiasis, give hope that the WHO’s
NTD paradigm, a ‘‘five-pronged’’ ap-
proach of 1) preventive chemotherapy, 2)
intensified case-management, 3) vector
control, 4) provision of safe water, sanita-
tion, and hygiene, and 5) veterinary public
health, are proving beneficial [1].
Malnutrition and unfulfilled human
potential are widely prevalent among the
1.4 billion people also afflicted by the
principal NTDs. Over the last decade, we
have become increasingly aware that
alterations in intestinal function not only
associate with malnutrition, but are likely
one of its driving forces. It was recognized
half a century ago that children in
developing countries had intestinal muco-
sa that showed morphological flattening
[4] and malabsorption [5] that were
reversible upon exposure to a cleaner
environment. Similarly, Lindenbaum also
showed in the 1960s that Peace Corps
volunteers with diarrhea and malnutrition
had biochemical markers of malabsorp-
tion: 40% had decreased d-xylose levels,
and 52% had low Schilling tests. More-
over, 88% of intestinal biopsies from these
volunteers showed mild to moderate
jejunitis with decreased villus:crypt ratios
[6].
Villus blunting along with chronic
inflammation associates with impaired
intestinal barrier function with resultant
increased intestinal permeability [7]. This
combination of altered villus architecture
and barrier function, so uniquely depen-
dent upon one’s environment, has been
termed ‘‘environmental enteropathy’’ (EE)
[8]. These characteristic EE changes have
been epidemiologically linked with growth
faltering and are one hypothesis for why
intensive nutritional supplementation in-
terventions done under even ideal clinical
trial conditions have significant but limited
success in improving weight, linear
growth, and cognitive function [9–11].
Syndemic with environmental enterop-
athy are high rates of childhood diarrhea.
Although children may display ‘‘catch-up’’
growth following isolated and short-lived
(3 days) diarrheal episodes [12], prolonged
and persistent diarrheal (.14 days) epi-
sodes strongly associate with stunting [13–
16]. Testament to the effectiveness of
WHO campaigns, the combination of oral
rehydration solution (ORS) in the 1980s
and its subsequent refinements, and the
introduction of rotavirus vaccines in some
populations [17], have led to significant
reductions in diarrhea-related mortality
from 4.5 million/year over a decade ago
to 1.5 million/year in 2010 [18,19].
Currently, however, there are still
.700,000 deaths per year globally related
to diarrheal diseases [20], and conversely,
the frequency of diarrheal episodes has not
declined but remains unacceptably high
[21]. Among the myriad pathogens caus-
ing diarrhea in low/middle-income coun-
tries, the protozoa Giardia lamblia (synony-
mous with G. intestinalis/G. duodenalis) and
Cryptosporidium spp. are among the most
commonly isolated [22]. Although present
in PLOS NTDs’ expanded NTD list [23],
and added to the WHO’s NDI in 2004
[2,24], these organisms are not mentioned
in the 2010 WHO NTD report [1].
Despite the call for increased surveillance
[2], the true global prevalence of these
infections remains poorly defined [25]. In
the past few years, we have learned
important lessons that make imperative
an emphasis on these ‘‘neglected enteric
protozoa’’ (NEP) and other enteropathy-
associated pathogens within the NDI:
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1. The enteric protozoa should be classi-
fied with the soil-transmitted helminths
(STHs) as pathogens associated with
stunting.
2. We need to restructure our theoretical
framework to broaden our concept of
‘‘diarrheal’’ disease to include ‘‘asymp-
tomatic’’ enteric infections.
3. We must recognize that environmental
enteropathy is likely both a common
and complex disease, and that infec-
tions related to the development or
exacerbation of environmental enter-
opathy deserve prioritization in disease
control strategies.
4. Therapeutic strategies against enterop-
athy-associated pathogens can and
should be evaluated for efficacy within
the existing NDI programs.
The NEP Belong with the STHs
as Stunting Pathogens
The NEP Cryptosporidium, E. histolytica,
and G. lamblia (as well as other entero-
pathogens such as enteroaggregative E. coli
[EAEC]) are increasingly recognized to be
associated with growth shortfalls [26–36].
Mondal et al. recently demonstrated that
stunted infants in Bangladesh were at
increased risk of severe diarrhea, and in
particular, diarrhea-associated E. histolytica
and Cryptosporidium infections [24]. The
impact of enteric protozoal infections has a
wide geographic distribution with specific
associations between Cryptosporidium and
malnutrition in Jamaica [27], Israel [28],
Peru [29], Mexico [30], Uganda [31],
Bangladesh [22,32,33], and Brazil [34–
36]. Furthermore, both Cryptosporidium and
variably Giardia associate with persistent
diarrhea [14,37]. Additionally, we have
found that even when controlled for
nutritional status, early childhood cryptos-
poridial infection either with or without
diarrhea was associated with reduced
fitness at 6–9 years of age and retarded
weight gain [37]. Also, similar to the
cognitive deficits seen in infestation with
STHs [38], Giardia has been associated
with decreased cognitive performance
[39–41]. The overall impact of even
‘‘asymptomatic’’ disease from enteric pro-
tozoa, therefore, may be a major contrib-
utor to lost human potential. Moreover,
the incoming field data from large multi-
center trials such as the Global Enterics
Multicenter Study (GEMS) [42] are dem-
onstrating a morass of diverse enteric
infections. Such infections occur both
concomitantly and sequentially with
STHs. It is quite plausible that along with
their individual impacts, there is a poten-
tially synergistic effect between STHs and
NEP whereby sequential hits affect chil-
dren at their most vulnerable ages and
serially interrupt crucial developmental
milestones. The growth impairments that
directly result from Cryptosporidium and
other enteropathogens (such as EAEC)
are clear not only from these field studies,
but also from animal models in which the
‘‘vicious cycle’’ of enteric infection and
malnutrition can be causally linked [43–
45]. Future investigations assessing the
long-term, and possibly permanent, im-
pact of these serial exposures into adult-
hood could be included in the assessments
of STH outcomes through NDI surveil-
lance.




The NEP may be signaling us to expand
our understanding of ‘‘diarrheal’’ disease.
Beginning with the pioneering work of L.
Mata, who showed that repeated episodes
of diarrheal disease were temporally linked
with associated linear growth shortfalls
[46], to the observations associating even
‘‘asymptomatic’’ enteric protozoa infec-
tions with developmental impairments, we
have been challenged to re-conceptualize
our traditional case definition of ‘‘diarrhe-
al’’ disease. The GEMS findings presented
at the recent American Society of Tropical
Medicine and Hygiene annual meeting
revealed that Cryptosporidium ranks highly
(in some populations, second only to
rotavirus) among all viral, bacterial, and
parasitic pathogens causing moderate to
severe diarrhea in children, and that the
parasite also associates with persistent
linear growth shortfalls [42]. The GEMS
investigators also recently published a
systematic review and meta-analysis dem-
onstrating that Giardia, present in .90% of
children in some populations by 12
months of age [22], was strongly associat-
ed with persistent diarrhea, but inversely
associated with acute diarrhea in endemic
settings [47]. Elsewhere, Giardia associates
with wasting (WAZ,22) [48,49] and
stunting [50,51], suggesting the parasite
(or particular G. lamblia strains) may have
an underappreciated influence on child-
hood development. Thus, as we had
discovered with the more readily identifi-
able STHs using stool microscopy, we
need to examine not only the overt liquid
diarrhea, but also developmental shortfalls
that may indicate a more silent and
ominous threat to human potential. In-
deed, restructured key ‘‘case’’ definitions
of disease resulting from enteric infections
will be critical to correctly determining the
true prevalence and impact of these
infections, and thus to prioritizing treat-
ment and prevention strategies in the most
appropriate manner.
Environmental Enteropathy Is
Likely both Common and
Complex
The mechanisms accounting for growth
impairments following infection are com-
plex, and they are likely intertwined with
environmental enteropathy. There is a
pathological basis for the NEP to poten-
tially initiate and/or propagate environ-
mental enteropathy. In murine models,
Cryptosporidium causes weight loss, villus
blunting, crypt hyperplasia, and increased
IFN-gamma and TNF-alpha reminiscent
of EE changes [44,52]. Chronic G. lamblia
infection in humans has also demonstrated
abnormalities in epithelial tight-junction
proteins (claudin-1) and altered mucosal
morphometry [53]. A better understand-
ing of the pathogenesis of the NEP and EE
and their developmental sequlae may help
to identify common pathways by which
certain enteric pathogens, together with
malnutrition, promote lost human poten-
tial. Such discoveries may open avenues
for new therapeutics that restore gut
function. Despite the aforementioned
foundational observations linking malnu-
trition, enteric infections, and alterations
in intestinal architecture, inflammation,
and function, it has taken many years to
begin to dissect the etiologies and mech-
anisms driving EE. One significant hurdle
to overcome is the challenge inherent in
studying a disease process that otherwise
requires endoscopy and tissue biopsy for
diagnosis. The pursuit for reliable non-
invasive biomarkers of EE that are readily
available and both sensitive and specific is
crucial for determining the true prevalence
of this condition, and for increasing our
understanding of its underlying patho-
physiology and disease modulators (i.e.,
differential effects from various pathogens
and co-pathogen infections, nutritional
status and micronutrient intake, host
genetics/epigenetics, and microbiota).
Studies are currently investigating several
leading candidate biomarkers found to be
elevated in children in low-income coun-
tries, including: markers of intestinal
inflammation such as fecal myeloperoxi-
dase (MPO), lactoferrin, and neopterin;
serum alpha-1 anti-trypsin (A1AT), a
marker of hyperpermeability and protein
wasting; and serum endotoxin core anti-
body (EndoCAb), a marker of bacterial
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translocation and systemic immune acti-
vation. Clinical Investigations in this field
have identified that elevated fecal lactofer-
rin and EndoCAb are present in malnour-
ished children and in certain enteric
infections, and that malnourished children
have increased lactulose:mannitol ratios
(L:M) [22,54]. A combination of these
candidate biomarkers or novel approaches
such as metabonomics are needed to begin
to truly appreciate the global prevalence,
spectrum, and impact of EE and the
differential influence NEP and other
pathogens have on its severity.
Strategies toward Reducing the
Burden of the NEP Can Be
Incorporated into Existing NDI
Programs
Even when not associated with diar-
rhea, the capacity of the NEP and other
enteropathy-associated pathogens to limit
human potential in populations living in
poverty, and the increasing recognition of
the systemic effects of EE, suggest that
novel strategies are needed to fully address
the burden of enteric pathogens. Though
provision of safe water and sanitation
should be universal, not all water purifi-
cation techniques are effective against the
chlorine-resistant and environmentally
hardy protozoa such as Cryptosporidium
spp. Therapeutic strategies are also need-
ed. As was recently demonstrated, mass
azithromycin distribution for trachoma
was associated with reduced all-cause
mortality and infectious childhood mor-
tality [55], a benefit that could be partially
attributed to decreased intestinal pathogen
burden [56]. Albendazole given in a 5-day
regimen has similar efficacy to metronida-
zole for Giardia [57], which could be
incorporated into mass de-worming cam-
paigns with extended therapy for Giardia-
endemic regions. The addition of nitazox-
anide as an anti-protozoal agent, and
more specifically for Cryptosporidium [58],
may synergize with azithromycin and
albendazole in mass preventive chemo-
therapy campaigns. Novel intestinal repair
therapies that could be added to the
presently recommended zinc supplemen-
tation need to be identified and incorpo-
rated as measures to combat the ‘‘vicious
malnutrition-enteric disease cycle’’
(Figure 1 [15]) [59,60].
We have here enumerated several
reasons why increased awareness of NEP
and other pathogens associated with
changes resembling EE is necessary to
achieve the NDI’s goals of eliminating
diseases of poverty. Environmental enter-
opathy, so intimately dependent upon
individuals’ surroundings, is perhaps our
closest physiopathological correlate to
poverty. Through its multi-pronged ap-
proach, including intensified case recogni-
tion and management, the NDI has the
existing infrastructure to take over where
decades of acute life-saving oral rehydrat-
ing therapy has left off, and begin to
reverse the trends of increasing diarrhea-
associated morbidities [21]. Alongside
efforts to combat STHs, we need aggres-
Figure 1. The ‘‘vicious cycle’’ of enteropathogens, malnutrition, and impaired childhood development, and multifaceted
opportunities for intervention. Figure adapted from Nutr Rev. 2008 September; 66(9): 487–505 [15].
doi:10.1371/journal.pntd.0002125.g001
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sive measures to address ‘‘stunting’’ and
‘‘wasting’’ enterics such as Cryptosporidium,
E. histolytica, G. lamblia, and other patho-
gens (i.e., EAEC) as they are identified.
Such measures will prove critical for the
more than one-third of the world’s chil-
dren among the ‘‘bottom billion’’ to
achieve their full human potential.
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43. Coutinho BP, Oriá RB, Vieira CM, Sevilleja JE,
Warren CA, et al. (2008) Cryptosporidium
infection causes undernutrition and, conversely,
weanling undernutrition intensifies infection.
J Parasitol 94: 1225–1232.
44. Costa LB, JohnBull EA, Reeves JT, Sevilleja JE,
Freire RS, et al. (2011). Cryptosporidium-malnu-
trition interactions: mucosal disruption, cytokines,
and TLR signaling in a weaned murine model.
J Parasitol 6: 1113–1120.
45. Roche JK, Cabel A, Sevilleja J, Nataro J,
Guerrant RL (2010) Enteroaggregative escherich-
ia coli (EAEC) impairs growth while malnutrition
worsens EAEC infection: A novel murine model
of the infection malnutrition cycle. J Infect Dis
202(4): 506–514.
46. Mata LJ (1978) The children of Santa Maria
Cauque: A prospective field study of health and
growth. Cambridge, MA: MIT Press.
47. Muhsen K, Levine M. (2012) A systematic review
and meta-analysis of the asssociation between G.
lamblia and endemic pediatric diarrhea in devel-
oping countries. Clin Inf Dis 55(4): S271–S293.
48. Al-Mekhlafi MS, Azlin M, Nor Aini U, Shaik A,
Sa’iah A, et al. (2005) Giardiasis as a predictor of
childhood malnutrition in Orang Asli children in
Malaysia. Trans R Soc Trop Med Hyg 99: 686–
691.
49. Carvalho-Costa FA, Gonçalves AQ, Lassance SL,
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